In our animal experiments, we used STZ to induce diabetes because STZ selectively destroys pancreatic islet β cells via the GLUT2 glucose transporter, which resulted in animals experiencing general characteristics of human diabetes such as hyperglycemia, polyuria, polydipsia and hyperphagia.22 This evidence concerns the gene SLC2A2 and Hyperglycemia.